Association of Glucose Concentrations at Hospital Discharge With Readmissions and Mortality: A Nationwide Cohort Study.
Aged
Biomarkers
/ analysis
Blood Glucose
/ metabolism
Cohort Studies
Diabetes Mellitus
/ metabolism
Female
Follow-Up Studies
Hospitalization
/ statistics & numerical data
Humans
Male
Mortality
/ trends
Patient Discharge
/ statistics & numerical data
Patient Readmission
/ statistics & numerical data
Prognosis
Survival Rate
Time Factors
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 09 2019
01 09 2019
Historique:
received:
30
11
2018
accepted:
04
04
2019
pubmed:
2
5
2019
medline:
28
5
2020
entrez:
2
5
2019
Statut:
ppublish
Résumé
Low blood glucose concentrations during the discharge day may affect 30-day readmission and posthospital discharge mortality rates. To investigate whether patients with diabetes and low glucose values during the last day of hospitalization are at increased risk of readmission or mortality. Minimum point of care glucose values were collected during the last 24 hours of hospitalization. We used adjusted rates of 30-day readmission rate, 30-, 90-, and 180-day mortality rates, and combined 30-day readmission/mortality rate to identify minimum glucose thresholds above which patients can be safely discharged. Nationwide cohort study including 843,978 admissions of patients with diabetes at the Veteran Affairs hospitals 14 years. The rate ratios (RRs) increased progressively for all five outcomes as the minimum glucose concentrations progressively decreased below the 90 to 99 mg/dL category, compared with the 100 to 109 mg/dL category: 30-day readmission RR, 1.01 to 1.45; 30-day readmission/mortality RR, 1.01 to 1.71; 30-day mortality RR, 0.99 to 5.82; 90-day mortality RR, 1.01 to 2.40; 180-day mortality RR, 1.03 to 1.91. Patients with diabetes experienced greater 30-day readmission rates, 30-, 90- and 180-day postdischarge mortality rates, and higher combined 30-day readmission/mortality rates, with glucose levels <92.9 mg/dL, <45.2 mg/dL, 65.8 mg/dL, 67.3 mg/dL, and <87.2 mg/dL, respectively. Patients with diabetes who had hypoglycemia or near-normal glucose values during the last day of hospitalization had higher rates of 30-day readmission and postdischarge mortality.
Identifiants
pubmed: 31042288
pii: 5433626
doi: 10.1210/jc.2018-02575
pmc: PMC6642668
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
3679-3691Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK111024
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028747
Pays : United States
Organisme : CSRD VA
ID : I01 CX001825
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK072488
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States
Informations de copyright
Published by Oxford University Press on behalf of the Endocrine Society 2019.
Références
Ann Thorac Surg. 2000 Jul;70(1):169-74
pubmed: 10921703
J Thorac Cardiovasc Surg. 2001 Aug;122(2):278-86
pubmed: 11479500
Diabetes Care. 2003 May;26(5):1421-6
pubmed: 12716799
Arch Intern Med. 2003 Aug 11-25;163(15):1825-9
pubmed: 12912719
Stat Med. 2003 Oct 15;22(19):3055-71
pubmed: 12973787
Diabetes Care. 2004 May;27 Suppl 2:B10-21
pubmed: 15113777
J Gen Intern Med. 2005 Apr;20(4):317-23
pubmed: 15857487
Circulation. 2005 Jun 14;111(23):3078-86
pubmed: 15939812
Am J Public Health. 2005 Sep;95(9):1561-7
pubmed: 16118367
Med Care. 2006 Mar;44(3):292-6
pubmed: 16501402
Rev Clin Esp. 2007 Jul-Aug;207(7):322-30
pubmed: 17662196
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Health Care Financ Rev. 2008 Fall;30(1):75-91
pubmed: 19040175
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
Arch Intern Med. 2009 Mar 9;169(5):438-46
pubmed: 19273773
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
BMJ. 2010 Jan 08;340:b4909
pubmed: 20061358
N Engl J Med. 2010 Oct 7;363(15):1410-8
pubmed: 20925543
JAMA. 2011 Oct 26;306(16):1794-5
pubmed: 22028355
J Clin Endocrinol Metab. 2012 Jan;97(1):16-38
pubmed: 22223765
Am J Med Qual. 2012 Nov-Dec;27(6):503-8
pubmed: 22539798
J Rural Health. 2012 Summer;28(3):227-34
pubmed: 22757946
J Diabetes Sci Technol. 2012 May 01;6(3):563-71
pubmed: 22768887
Ann Intern Med. 2012 Dec 18;157(12):837-45
pubmed: 23247937
Diabetes Care. 2013 Apr;36(4):1033-46
pubmed: 23468086
Diabetes Care. 2013 Oct;36(10):2960-7
pubmed: 23835695
Diabetes Care. 2013 Dec;36(12):4091-7
pubmed: 24170754
Endocr Pract. 2014 Sep;20(9):870-5
pubmed: 24641928
Biomed Res Int. 2014;2014:781670
pubmed: 24804245
JAMA Intern Med. 2014 Jul;174(7):1116-24
pubmed: 24838229
Diabetes Care. 2014 Nov;37(11):2934-9
pubmed: 25168125
Curr Diab Rep. 2015 Apr;15(4):17
pubmed: 25712258
Endocr Pract. 2016 Oct;22(10):1204-1215
pubmed: 27732098
J Diabetes Complications. 2017 Jan;31(1):122-127
pubmed: 27838101
J Clin Endocrinol Metab. 2017 Feb 1;102(2):416-424
pubmed: 27854553
Am J Cardiol. 2017 Jun 15;119(12):1917-1923
pubmed: 28427734
Clin Diabetes Endocrinol. 2017 Mar 22;3:3
pubmed: 28702257
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
Acta Med Scand. 1988;224(1):31-8
pubmed: 3046232
J Stroke Cerebrovasc Dis. 2019 Mar;28(3):619-626
pubmed: 30545720
J Gen Intern Med. 1987 Nov-Dec;2(6):400-5
pubmed: 3694300
Biometrics. 1986 Mar;42(1):121-30
pubmed: 3719049
Diabetes Care. 1996 Jul;19(7):698-703
pubmed: 8799622
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328